Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis

References

• Ciotti, M., Lakshmi, V. M., Basu, N., Davis, B. B., Owens, I. S., and Zenser, T. V. 1999. Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferase and pH stability of glucuronides. Carcinogenesis 20: 1963–1969.
   PubMed Web of Science ®Google Scholar
• Djukic, T. I., Savic-Radojevic, A. R., Pekmezovic, T. D., Matic, M. G., Pljesa-Ercegovac, M. S., Coric, V. M., Radic, T. M., Suvakov, S. R., Krivic, B. N., Dragicevic, D. P., and Simic, T. P. 2013. Glutathione S-transferase T1, O1 and O2 polymorphisms are associated with survival in muscle invasive bladder cancer patients. PLoS One 8: e74724.
   PubMed Web of Science ®Google Scholar
• García-Closas, M., Malats, N., Silverman, D., Dosemeci, M., Kogevinas, M., Hein, D. W., Tardón, A., Serra, C., Carrato, A., García-Closas, R., Lloreta, J., Castaño-Vinyals, G., Yeager, M., Welch, R., Chanock, S., Chatterjee, N., Wacholder, S., Samanic, C., Torà, M., Fernández, F., Real, F. X., and Rothman, N. 2005. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366: 649–659.
   PubMed Web of Science ®Google Scholar
• Ginsberg, G., Smolenski, S., Hattis, D., Guyton, K. Z., Johns, D. O., and Sonawane, B. 2009. Genetic polymorphism in glutathione transferases (GST): Population distribution of GSTM1, T1 and P1 activity. J. Toxicol. Environ. Health B 12: 389–439.
   PubMed Web of Science ®Google Scholar
• Golka, K., Reckwitz, T., Kempkes, M., Cascorbi, I., Blaskewicz, M., Reich, S. E., Roots, I., Sökeland, J., Schulze, H., and Bolt, H. M. 1997. N-Acetyltransferase 2 (NAT2) and glutathione S-transferase μ (GSTM1) in bladder-cancer patients in a highly industrialized area. Int. J. Occup. Environ. Health 3: 105–110.
   PubMedGoogle Scholar
• Golka, K., Prior, V., Blaszkewicz, M., and Bolt H. M. 2002. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: A review considering ethnic differences. Toxicol. Lett. 128: 229–241.
   PubMed Web of Science ®Google Scholar
• Golka, K., Hermes, M., Selinski, S., Blaszkewicz, M., Bolt, H. M., Roth, G., Dietrich, H., Prager, H. M., Ickstadt, K., and Hengstler, J. G. 2009. Susceptibility to urinary bladder cancer: Relevance of rs9642880[T], GSTM1 0/0 and occupational exposure. Pharmacogenet. Genomics 19: 903–906.
   PubMed Web of Science ®Google Scholar
• Gong, M., Dong, W., and An, R. 2012. Glutathione S-transferase T1 polymorphism contributes to bladder cancer risk: A meta-analysis involving 50 studies. DNA Cell Biol. 31: 1187–1197.
   PubMed Web of Science ®Google Scholar
• Grotenhuis, A. J., Dudek, A. M., Verhaegh, G. W., Witjes, J. A., Aben, K. K., van der Marel, S. L., Vermeulen, S. H., and Kiemeney, L. A. 2014. Prognonostic relevance of urinary bladder cancer susceptibility loci. PLoS One 9: e89164.
   PubMed Web of Science ®Google Scholar
• Grotenhuis, A. J., Ebben, C. W., Aben, K. K., Witjes, J. A., Vrieling, A., Vermeulen, S. H., and Kiemeney, L. A. 2015. The effect of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer. Urol. Oncol. 33: 1–9.
   Web of Science ®Google Scholar
• Ha, Y. S., Yan, C., Jeong, P., Kim, W. T., Yun, S. J., Kim, I. Y., Moon, S. K., and Kim, W. J. 2011. GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer. J. Korean Med. Sci. 26: 231–236.
   PubMed Web of Science ®Google Scholar
• Ha, Y. S., Yan, C., Lym, M. S., Jeong, P., Kim, W. T., Kim, Y. J., Yun, S. J., Lee, S. C., Moon, S. K., Choi, Y. H., and Kim, W. J. 2010. GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer. Dis. Markers 29: 81–87.
   PubMed Web of Science ®Google Scholar
• Hoffman, B., and Liebermann, D. A. 2008. Apoptotic signaling by c-MYC. Oncogene 27: 6462–6472.
   PubMed Web of Science ®Google Scholar
• Hung, R. J., Boffetta, P., Brennan, P., Malaveille, C., Hautefeuille, A., Donato, F., Gelatti, U., Spaliviero, M., Placidi, D., Carta, A., Scotto di Carlo, A., and Porru, S. 2004. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int. J. Cancer 110: 598–604.
   PubMed Web of Science ®Google Scholar
• Kiemeney, L. A., Thorlacius, S., Sulem, P., Geller, F., Aben, K. K., Stacey, S. N., Gudmundsson, J., Jakobsdottir, M., Bergthorsson, J. T., Sigurdsson, A., Blondal, T., Witjes, J. A., Vermeulen, S. H., Hulsbergen-van de Kaa, C. A., Swinkels, D. W., Ploeg, M., Cornel, E. B., Vergunst, H., Thorgeirsson, T. E., Gudbjartsson, D., Gudjonsson, S. A., Thorleifsson, G., Kristinsson, K. T., Mouy, M., Snorradottir, S., Placidi, D., Campagna, M., Arici, C., Koppova, K., Gurzau, E., Rudnai, P., Kellen, E., Polidoro, P., Guarrera, S., Sacerdote, C., Sanchez, M., Saez, B., Valdivia, G., Ryk, C., de Verdier, P., Lindblom, A., Golka, K., Bishop, D. T., Knowles, M. A., Nikulasson, S., Petursdottir, V., Jonsson, E., Geirsson, G., Kristjansson, B., Mayordomo, J. I., Steineck, G., Porru, S., Buntinx, F., Zeegers, M. P., Fletcher, T., Kumar, R., Matullo, G., Vineis, P., Kiltie, A. E., Gulcher, J. R., Thorsteinsdottir, U., Kong, A., Rafnar, T., and Stefansson, K. 2008. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet. 40: 1307–1312.
   PubMed Web of Science ®Google Scholar
• Klein, T., Selinski, S., Blaszkewicz, M., Hengstler, J. G., and Golka, K. 2012. Indication for joint replacement and glutathione S-transferases M1 and T1 genotypes. J. Toxicol. Environ. Health A 75: 597–601.
   PubMed Web of Science ®Google Scholar
• Krech, E., Selinski, S., Blaszkewicz, M., Bürger, H., Kadhum, T. Hengstler, J. G., Truss M. C., and Golka, K. 2017. Urinary bladder cancer risk factors in an area of former coal, iron and steel industries in Germany. J. Toxicol. Environ. Health A. DOI: 10.1080/10937404.2017.1304719
   Google Scholar
• Lacombe, L., Fradet, V., Lévesque, É., Pouliot, F., Larue, H., Bergeron, A., Hovington, H., Caron, A., Nguile-Makao, M., Harvey, M., Fradet, Y., and Guillemette, C. 2016. Phase II drug-metabolizing polymorphisms and smoking predict recurrence of non-muscle-invasive bladder cancer: A gene-smoking interaction. Cancer Prev. Res. (Phila.) 9: 189–195.
   PubMed Web of Science ®Google Scholar
• Lehmann, M. L., Selinski, S., Blaszkewicz, M., Orlich, M., Ovsiannikov, D., Moormann, O., Guballa, C., Kress, A., Truss, M. C., Gerullis, H., Otto T., Barski, D., Niegisch, G., Albers, P., Frees, S., Brenner, W., Thüroff, J. W., Angeli-Greaves, M., Seidel, T., Roth, G., Dietrich, H., Ebbinghaus, R., Prager, H. M., Bolt, H. M., Falkenstein, M., Zimmermann, A., Klein, T., Reckwitz, T., Roemer, H. C., Löhlein, D., Weistenhöfer, W., Schöps, W., Beg, A. E., Aslam, M., Bánfi, G., Romics, I., Ickstadt, K., Schwender, H., Winterpacht, A., Hengstler, J. G., and Golka, K. 2010. Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk. Arch. Toxicol. 84: 967–978.
   PubMed Web of Science ®Google Scholar
• Li, N., and Stephens, M. 2003. Modelling linkage disequilibrium, and identifying recombination hotspots using SNP data. Genetics 165: 2213–2233.
   PubMed Web of Science ®Google Scholar
• Lin, G. F., Guo, W. C., Chen, J. G., Qin, Y. Q., Golka, K., Xiang, C. Q., Ma, Q. W., Lu, D. R., and Shen, J. H. 2005. An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China. Toxicol. Sci. 85: 502–506.
   PubMed Web of Science ®Google Scholar
• Moore, L. E., Baris, D. R., Figueroa, J. D., Garcia-Closas, M., Karagas, M. R., Schwenn, M. R., Johnson, A. T., Lubin, J. H., Hein, D. W., Dagnall, C. L., Colt, J. S., Kida, M., Jones, M. A., Schned, A. R., Cherala, S. S., Chanock, S. J., Cantor, K. P., Silverman, D. T., and Rothman, N. 2011. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: Results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis 32: 182–189.
   PubMed Web of Science ®Google Scholar
• Nørskov, M. S., Frikke-Schmidt, R., Bojesen, S. E., Nordestgaard, B. G., Loft, S., and Tybjærg-Hansen, A. 2011. Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population. Pharmacogenomics J. 11: 292–299.
   PubMed Web of Science ®Google Scholar
• Ogihara, K., Kikuchi, E., Yuge, K., Ito, Y., Tanaka, N., Matsumoto, K., Miyajima, A., Asakura, H., and Oya, M. 2016. Refraining from smoking for 15 years or more reduced the risk of tumor recurrence in non-muscle invasive bladder cancer patients. Ann. Surg. Oncol. 23: 1752–1759.
   Web of Science ®Google Scholar
• Ovsiannikov, D., Selinski, S., Lehmann, M. L., Blaszkewicz, M., Moormann, O., Haenel, M. W., Hengstler, J. G., and Golka, K. 2012. Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry. J. Toxicol. Environ. Health A 75: 557–565.
   PubMed Web of Science ®Google Scholar
• Pesch, B., Gawrych, K., Rabstein, S., Weiss, T., Casjens, S., Rihs, H. P., Ding, H., Angerer, J., Illig, T., Klopp, N., Bueno-de-Mesquita, B., Ros, M. M., Kaaks, R., Chang-Claude, J., Roswall, N., Tjønneland, A., Overvad, K., Clavel-Chapelon, F., Boutron-Ruault, M. C., Dossus, L., Boeing, H., Weikert, S., Trichopoulos, D., Palli, D., Sieri, S., Tumino, R., Panico, S., Quirós, J. R., González, C., Sánchez, M. J., Dorronsoro, M., Navarro, C., Barricarte, A., Ljungberg, B., Johansson, M., Ulmert, D., Ehrnström, R., Khaw, K. T., Wareham, N., Key, T. J., Ferrari, P., Romieu, I., Riboli, E., Brüning, T., and Vineis, P. 2013. N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: Results from the EPIC cohort. Cancer Epidemiol. Biomarkers Prev. 22: 2055–2065.
   PubMed Web of Science ®Google Scholar
• R Core Team 2015. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing https://www.R-project.org
   Google Scholar
• Rink, M., Furberg, H., Zabor, E. C., Xylinas, E., Babjuk, M., Pycha, A., Lotan, Y., Karakiewicz, P. I., Novara, G., Robinson, B. D., Montorsi, F., Chun, F. K., Scherr, D. S., and Shariat, S. F. 2013. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur. Urol. 63: 724–732.
   PubMed Web of Science ®Google Scholar
• Roth, E., Selinski, S., Schikowsky, C., Seidel, T., Volkert, F., Blaszkewicz, M., Hengstler, J. G., and Golka, K. 2012. Bladder cancer survival in a former industrial area in Saxony-Anhalt, Germany. J. Toxicol. Environ. Health A 75: 1216–1225.
   PubMed Web of Science ®Google Scholar
• Rothman, N., Garcia-Closas, M., Chatterjee, N., Malats, N., Wu, X., Figueroa, J. D., Real, F. X., Van Den Berg, D., Matullo, G., Baris, D., Thun, M., Kiemeney, L. A., Vineis, P., De Vivo, I., Albanes, D., Purdue, M. P., Rafnar, T., Hildebrandt, M. A., Kiltie, A. E., Cussenot, O., Golka, K., Kumar, R., Taylor, J. A., Mayordomo, J. I., Jacobs, K. B., Kogevinas, M., Hutchinson, A., Wang, Z., Fu, Y. P., Prokunina-Olsson, L., Burdett, L., Yeager, M., Wheeler, W., Tardón, A., Serra, C., Carrato, A., García-Closas, R., Lloreta, J., Johnson, A., Schwenn, M., Karagas, M.R., Schned, A., Andriole, G. Jr, Grubb, R. 3rd, Black, A., Jacobs, E. J., Diver, W. R., Gapstur, S. M., Weinstein, S. J., Virtamo, J., Cortessis, V. K., Gago-Dominguez, M., Pike, M. C., Stern, M. C., Yuan, J. M., Hunter, D. J., McGrath, M., Dinney, C. P., Czerniak, B., Chen, M., Yang, H., Vermeulen, S. H., Aben, K. K., Witjes, J. A., Makkinje, R. R., Sulem, P., Besenbacher, S., Stefansson, K., Riboli, E., Brennan, P., Panico, S., Navarro, C., Allen, N. E., Bueno-de-Mesquita, H. B., Trichopoulos, D., Caporaso, N., Landi, M. T., Canzian, F., Ljungberg, B., Tjonneland, A., Clavel-Chapelon, F., Bishop, D. T., Teo, M. T., Knowles, M. A., Guarrera, S., Polidoro, S., Ricceri, F., Sacerdote, C., Allione, A., Cancel-Tassin, G., Selinski, S., Hengstler, J. G., Dietrich, H., Fletcher, T., Rudnai, P., Gurzau, E., Koppova, K., Bolick, S. C., Godfrey, A., Xu, Z., Sanz-Velez, J. I., D. García-Prats, M., Sanchez, M., Valdivia, G., Porru S., Benhamou S., Hoover, R. N., Fraumeni, J. F. Jr, Silverman, D. T., and Chanock, S. J. 2010. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet. 42:978–984.
   PubMed Web of Science ®Google Scholar
• Rushton, L., Hutchings, S. J., Fortunato, L., Young, C., Evans, G. S., Brown, T., Bevan, R., Slack, R., Holmes, P., Bagga, S., Cherrie, J. W., and Van Tongeren, M. 2012. Occupational cancer burden in Great Britain. Br. J. Cancer 107(Suppl 1): S3–S7.
   PubMed Web of Science ®Google Scholar
• SAS/STAT® software, version 9.2. Copyright © 2002–2008, Cary, NC, USA: SAS Institute Inc.
   Google Scholar
• Selinski, S., Blaszkewicz, M., Ickstadt, K., Hengstler, J. G., and Golka, K. 2013. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk. Arch. Toxicol. 87: 2129–2139.
   PubMed Web of Science ®Google Scholar
• Selinski, S. 2014. Urinary bladder cancer risk variants: Recent findings and new challenges of GWAS and confirmatory studies. Arch. Toxicol. 88: 1469–1475.
   PubMed Web of Science ®Google Scholar
• Selinski S., Lehmann M. L., Blaszkewicz M., Ovsiannikov D., Moormann O., Guballa C., Kress A., Truß M. C., Gerullis H., Otto T., Barski D., Niegisch G., Albers P., Frees S., Brenner W., Thüroff J. W., Angeli-Greaves M., Seidel T., Roth G., Volkert F., Ebbinghaus R., Prager H.M., Bolt H.M., Falkenstein M., Zimmermann A., Klein T., Reckwitz T., Roemer H. C., Hartel M., Weistenhöfer W., Schöps W., Rizvi S. A., Aslam M., Bánfi G., Romics I., Ickstadt K., Hengstler J. G., Golka K. 2012. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk. Arch. Toxicol. 86: 1369–1378.
   Google Scholar
• Stephens, M., and Donnelly, P. 2003. A comparison of Bayesian methods for haplotype reconstruction. Am. J. Hum. Genet. 73: 1162–1169.
   PubMed Web of Science ®Google Scholar
• Stephens, M., Smith, N. J., and Donnelly, P. 2001. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68: 978–989.
   PubMed Web of Science ®Google Scholar
• Therneau, T. 2015. A Package for Survival Analysis in S. Version 2.38. Available at http://CRAN.R-project.org/package=survival (accessed November 2015).
   Google Scholar
• Walker, K., Ginsberg, G., Hattis, D., Johns, D. O., Guyton, K. Z., and Sonawane, B. 2009. Genetic polymorphism in N-acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity. J. Toxicol. Environ. Health B 12: 440–472.
   PubMed Web of Science ®Google Scholar
• Wallig, M. A. 2004. Glucuronidation and susceptibility to chemical carcinogenesis. Toxicol. Sci. 78: 1–2.
   PubMed Web of Science ®Google Scholar
• Wyszynski, A., Tanyos, S. A., Rees, J. R., Marsit, C. J., Kelsey, K. T., Schned, A. R., Pendleton, E. M., Celaya, M. O., Zens, M. S., Karagas, M. R., and Andrew, A. S. 2014. Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancer 120: 408–414.
   PubMed Web of Science ®Google Scholar
• Wu, B., Dong, D., Hu, M., and Zhang, S. 2013. Quantitative prediction of glucuronidation in humans using the in vitro- in vivo extrapolation approach. Curr. Top. Med. Chem. 13: 1343–1352.
   PubMed Web of Science ®Google Scholar
• Zhang, R., Xu, G., Chen, W., and Zhang, W. 2011. Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: A meta-analysis of 26 studies. Mol. Biol. Rep. 38: 2491–2497.
   PubMed Web of Science ®Google Scholar
• Zimmermann, A., Blaszkewicz, M., Roth, G., Seidel, T., Dietrich, H., Schutschkow, O., Bolt, H. M., and Golka, K. 2008. UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism in bladder cancer cases. J. Toxicol. Environ. Health A 71: 911–914.
   PubMed Web of Science ®Google Scholar
• Zimmermann, A., Ebbinghaus, R., Prager, H. M., Blaszkewicz, M., Hengstler, J. G., and Golka, K. 2012. Miners compensated for pneumoconiosis and glutathione S-transferases M1 and T1 genotypes. J. Toxicol. Environ. Health A 75: 582–587.
   PubMed Web of Science ®Google Scholar